Table 3.
Short-Term Outcomes Among White and Black Veterans With Clinical Stage I NSCLC Undergoing Resection in the VHA
| Outcome | White (n = 8,360) | Black (n = 1,486) | P Value |
|---|---|---|---|
| Length of stay, mean ± SD, d | 8.4 ± 6.9 | 8.1 ± 6.9 | .122 |
| Pathologic upstage | 983 (11.8) | 184 (12.4) | .644 |
| Positive surgical margins | 260 (3.1) | 47 (3.2) | .955 |
| Major complication | 956 (11.4) | 150 (10.1) | .130 |
| Complications | |||
| Pneumonia | 537 (6.4) | 81 (5.5) | .153 |
| Myocardial infarction | 90 (1.1) | 9 (0.6) | .094 |
| Empyema | 83 (1.0) | 7 (0.5) | .072 |
| Renal failure | 114 (1.4) | 36 (2.4) | .002 |
| Respiratory/cardiac failure | 458 (5.5) | 74 (5.0) | .431 |
| Stroke | 31 (0.4) | 5 (0.3) | .840 |
| 30-Day readmission | 651 (7.8) | 153 (10.3) | .001 |
| 30-Day mortality | 175 (2.1) | 32 (2.2) | .884 |
| 90-Day mortality | 340 (4.1) | 54 (3.6) | .433 |
| Adjuvant chemotherapy | 966 (11.6) | 218 (14.8) | < .001 |
Data are expressed as No. (%) unless otherwise indicated. NSCLC = non-small cell lung cancer; VHA = Veterans Health Administration.